On Friday, Axonics Inc (AXNX) stock saw a decline, ending the day at $69.15 which represents a decrease of $-0.10 or -0.14% from the prior close of $69.25. The stock opened at $69.26 and touched a low ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Buy AXNX near 68.15 target 71.79 stop loss @ 67.95 Details The technical summary data tells us to buy AXNX near 68.15 with an upside target of 71.79. This data also tells us to set a stop loss @ 67.95 ...

Note: They also have a larger long position that offsets this short stake. Axonics, Inc. (AXNX): AXNX is a 2.14% of the portfolio position primarily built this quarter at prices between $66.47 and ...

Guangqiang Jiang has an estimated net worth of $13.9 Million. This is based on reported shares in Axonics Modulation Technologies, Inc.. Attention insiders: Dive deeper into market movements and ...